CMG Pharmaceutical Co. Ltd (058820) — Strategic Asset Allocation Index
CMG Pharmaceutical Co. Ltd (058820) has a Strategic Asset Allocation Index of 42.6% as of March 2025. Strategic assets (PP&E of ₩79.99 Billion plus long-term investments of ₩-) total ₩79.99 Billion, measured against net assets of ₩187.98 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is CMG Pharmaceutical Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
CMG Pharmaceutical Co. Ltd Strategic Asset Allocation Index (2011–2024)
This chart shows how CMG Pharmaceutical Co. Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of March 2025, the index stands at 42.6%, representing strategic assets of ₩79.99 Billion against net assets of ₩187.98 Billion KRW. For live market cap and overall valuation, see CMG Pharmaceutical Co. Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for CMG Pharmaceutical Co. Ltd (2011–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for CMG Pharmaceutical Co. Ltd from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CMG Pharmaceutical Co. Ltd (058820) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 41.1% | ₩77.98 Billion | ₩77.98 Billion | ₩- | ₩189.54 Billion | ▲ +14.5 pp |
| 2023 | 26.7% | ₩50.71 Billion | ₩50.71 Billion | ₩- | ₩190.23 Billion | ▲ +6.4 pp |
| 2022 | 20.3% | ₩37.47 Billion | ₩37.47 Billion | ₩- | ₩184.95 Billion | ▲ +3.7 pp |
| 2021 | 16.5% | ₩30.52 Billion | ₩30.52 Billion | ₩- | ₩184.70 Billion | ▲ +0.1 pp |
| 2020 | 16.4% | ₩29.74 Billion | ₩29.74 Billion | ₩- | ₩181.13 Billion | ▲ +3.0 pp |
| 2019 | 13.4% | ₩24.12 Billion | ₩24.12 Billion | ₩- | ₩180.16 Billion | ▼ -7.7 pp |
| 2018 | 21.1% | ₩21.93 Billion | ₩17.27 Billion | ₩4.66 Billion | ₩103.98 Billion | ▲ +0.3 pp |
| 2017 | 20.8% | ₩20.34 Billion | ₩16.18 Billion | ₩4.15 Billion | ₩97.94 Billion | ▲ +2.8 pp |
| 2016 | 18.0% | ₩18.21 Billion | ₩16.91 Billion | ₩1.30 Billion | ₩101.11 Billion | ▼ -20.5 pp |
| 2015 | 38.5% | ₩18.02 Billion | ₩17.82 Billion | ₩202.00 Million | ₩46.81 Billion | ▼ -0.3 pp |
| 2014 | 38.8% | ₩19.04 Billion | ₩18.83 Billion | ₩202.00 Million | ₩49.00 Billion | ▲ +16.8 pp |
| 2013 | 22.1% | ₩10.81 Billion | ₩10.81 Billion | ₩- | ₩49.00 Billion | ▼ -7.4 pp |
| 2012 | 29.5% | ₩9.31 Billion | ₩9.31 Billion | ₩- | ₩31.59 Billion | ▼ -24.4 pp |
| 2011 | 53.8% | ₩9.71 Billion | ₩9.71 Billion | ₩- | ₩18.03 Billion | — |